Industry Experts

After obtaining my PhD in Biotechnology at Ghent University/Flemish Institute of Biotechnology (VIB), I joined Ablynx in 2013 as Scientist in the Pharmacology department, where I supported and coordinated preclinical and clinical Pharmacology NANOBODY® programs across different indications. After acquisition of Ablynx by Sanofi in 2018, I transitioned to a Project Head role in the Innovation team of Large Molecule Research Platform. Since then, I have led several Innovative Research Projects, both internal as external collaborations and am leading a small subteam of Project heads at the Sanofi Ghent site